Evidence map›Paper›PMID 41219790›Full record

ArticleMolecular cancer2025

A novel protein cPFKFB4 encoded by hsa_circ_0065394 strengthens PKM2-mediated glucose metabolic reprogramming to facilitate pancreatic cancer progression under hypoxia.

Hang Chen, Molin Li, Fuming Xie, Shan Liu, Aining Yang, Jingyang Yin, Xianxing Wang, Yuxi Long, Shitao Wu, Lei Cai and 2 more

Abstract read
In one paragraph

Article in Molecular cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. METTL3-driven mJournal of translational medicine · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hang Chen *Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, China. chendahang@cqu.edu.cn.
Molin Li *Department of Pathology, Chongqing General Hospital, Chongqing University, Chongqing, 401147, China.
Fuming Xie *Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, China.
Shan LiuDepartment of Anesthesiology, Chongqing Seventh People's Hospital, Chongqing University of Technology, Chongqing, 400054, China.
Aining YangInternational Nursing College, Hainan Vocational University of Science and Technology, Hainan, 571126, China.
Jingyang YinInstitute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, China.
Xianxing WangInstitute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, China.
Yuxi LongInstitute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, China.
Shitao WuInstitute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, China.
Lei CaiInstitute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, China. cailei@rocketmail.com.
Junxia ChenBasic Medical College, Chongqing Medical University, Chongqing, 400016, China. chjunxia@126.com.
Huaizhi WangInstitute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, China. whuaizhi@gmail.com.

Funding

Tri-Institutional PhD Program in Computational Biology & MedicineT32GM132083 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Doron Betel, Iman Hajirasouliha · 2020 to 2026
$3.6M
Chongqing Medical Youth Top-notch Talent Project YXQN202560Chongqing Municipal Human Resources and Social Security Bureau 2024CQBSHTB3084Chongqing Science and Health Joint Medical Research Major Project 2024DBXM003Chongqing Technology Innovation and Application Development Special Key Project CSTB2022TIAD-KPX0170Medical Research Foundation of Chongqing General Hospital Y2023YXYJMSXM01National Natural Science Foundation of China 82403212Natural Science Foundation of Chongqing Municipality CSTB2024NSCQ-MSX0166NIGMS NIH HHS T32 GM132083
6 · The paper itself

Abstract

backgroundHypoxia is a hallmark of solid tumors and gives rise to the glucose metabolic reprogramming of cancers. Peptides and proteins encoded by circular RNAs (circRNAs) are identified as pivotal mediators in the malignant progression of tumors. Nonetheless, proteins encoded by hypoxia-related circRNAs in pancreatic cancer (PC) remain uncharacterized and poorly understood.

methodsHypoxia-responsive circRNA (hsa_circ_0065394) in PC was screened using a hypoxic culture system. The circularization mechanism of hsa_circ_0065394 was investigated by employing bioinformatics and RNA immunoprecipitation. An assessment of the expression profile and potential clinical significance of hsa_circ_0065394 in PC was conducted utilizing qRT-PCR and in situ hybridization. Dual-luciferase reporter gene assay, mass spectrometry and western blotting identified a protein cPFKFB4 encoded by hsa_circ_0065394. The biological functions of cPFKFB4 were verified by gain- and loss-of-function experiments in vivo and in vitro. From a mechanistic standpoint, how cPFKFB4 modulates the interaction between hnRNP G and hnRNP A1 as well as the regulation of PKM alternative splicing was explored by conducting mass spectrometry, co-immunoprecipitation, immunofluorescence, PKM splicing, RNA immunoprecipitation, western blotting, and rescue experiments.

resultsHypoxia-associated hsa_circ_0065394 was noticeably up-regulated in PC tissues and tightly associated with tumor size. The biological cyclization of hsa_circ_0065394 was mediated by hnRNP L and Alu repeat sequences. Mechanistically, hsa_circ_0065394 encoded a 94 amino acid protein cPFKFB4 through a cap-independent mechanism. cPFKFB4 disrupted the hnRNP G-hnRNP A1 complex through specific binding to hnRNP G, facilitated hnRNP A1-mediated regulation of PKM alternative splicing, thereby heightening the expression of PKM2, and then strengthening glycolysis of PC cells to accelerate the proliferation and metastasis of PC under hypoxic conditions.

conclusionscPFKFB4, a protein encoded by hypoxia-responsive circular RNA, facilitates the proliferation and metastasis of PC cells under hypoxic conditions by regulating PKM2-mediated glycolysis. Our findings not only offer fresh standpoints and valuable insights into the crosstalk between hypoxia, glucose metabolism reprogramming, and PC, but also provide a potential biomarker and therapeutic target for the treatment of PC.

Indexed as

Carrier ProteinsGlucoseMembrane ProteinsPancreatic NeoplasmsRNA, CircularThyroid HormonesAnimalsCell HypoxiaCell Line, TumorCell ProliferationDisease ProgressionGene Expression Regulation, NeoplasticHeterogeneous Nuclear Ribonucleoprotein A1HumansMetabolic ReprogrammingMiceCarrier ProteinsGlucoseHeterogeneous Nuclear Ribonucleoprotein A1Membrane ProteinsRNA, CircularThyroid Hormone-Binding ProteinsThyroid HormonescPFKFB4GlycolysisHypoxiaPancreatic cancerPyruvate kinase m splicing

Identifiers

PMID41219790
PMCPMC12607072

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.